References:
1. Hirabayashi S, Ohki K, Nakabayashi K, et al. ZNF384-related fusion
genes define a subgroup of childhood B-cell precursor acute
lymphoblastic leukemia with a characteristic immunotype.Haematologica . 2017;102:118-129.
2. Alexander TB, Gu Z, Iacobucci I, et al. The genetic basis and cell of
origin of mixed phenotype acute leukaemia. Nature .
2018;562:373-379.
3. McClure BJ, Heatley SL, Kok CH, et al. Pre-B acute lymphoblastic
leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct
gene expression. Br J Cancer . 2018;118:1000-1004.
4. Roy P, Narula G, Arora B, et al. Implementation of risk adapted
therapeutic strategy for childhood acute lymphoblastic leukaemia –
interim report of the pilot InPOG-ALL-15-01 study. Pediatr Hematol
Oncol J . 2018;3:S19.
5. Oberley MJ, Gaynon PS, Bhojwani D, et al. Myeloid lineage switch
following chimeric antigen receptor T-cell therapy in a patient with
TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia. Pediatr
Blood Cancer . 2018;65:e27265.
6. Aldoss I, Song JY. Extramedullary relapse of KMT2A(MLL)-rearranged
acute lymphoblastic leukemia with lineage switch following blinatumomab.Blood . 2018;131:2507.
7. Balducci E, Nivaggioni V, Boudjarane J, et al. Lineage switch from B
acute lymphoblastic leukemia to acute monocytic leukemia with persistent
t(4;11)(q21;q23) and cytogenetic evolution under CD19-targeted therapy.Ann Hematol . 2017;96:1579-1581.
8. Rayes A, McMasters RL, O’Brien MM. Lineage Switch in MLL-Rearranged
Infant Leukemia Following CD19-Directed Therapy. Pediatr Blood
Cancer . 2016;63:1113-1115.
9. Grammatico S, Vitale A, La Starza R, et al. Lineage switch from pro-B
acute lymphoid leukemia to acute myeloid leukemia in a case with
t(12;17)(p13;q11)/TAF15-ZNF384 rearrangement. Leuk Lymphoma .
2013;54:1802-1805.
10. Zoghbi A, Zur Stadt U, Winkler B, Müller I, Escherich G. Lineage
switch under blinatumomab treatment of relapsed common acute
lymphoblastic leukemia without MLL rearrangement. Pediatr Blood
Cancer . 2017;64.
11. Jacoby E, Nguyen SM, Fountaine TJ, et al. CD19 CAR immune pressure
induces B-precursor acute lymphoblastic leukaemia lineage switch
exposing inherent leukaemic plasticity. Nat Commun . 2016;7:12320.
12. Dorantes-Acosta E, Pelayo R. Lineage switching in acute leukemias: a
consequence of stem cell plasticity? Bone Marrow Res .
2012;2012:406796.